6-Chloro-4-formylpyridine-3-carboxylic acid, 95+%, 1g

Nitrometano, mínimo 98,5 %, para síntesis, 500 ml, envase de vidrio

2-(2-((3-Fluorobenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

5,6-Dibromo-1,2-dihydroacenaphthylene, 95.0%, 1g

(S)-3-(3-Aminophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 1g

TERT-BUTYL 3-(NITROMETHYLENE)AZETIDINE-1-CARBOXYLATE, 95.0%, 10g

2-(2,4-Dimethylbenzoyl)-5-methylpyridine, 97.0%, 1g

1-BROMO-2-CHLORO-5-FLUORO-3-NITROBENZENE, 95.0%, 250mg

Imidazo[1,2-a]pyrimidin-2-ylmethanamine, 95.0%, 100mg

2-(Thiophene-2-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 97%, 100mg

3-(tert-Butyl)-1,2,4-thiadiazol-5-amine, 95.0%, 5g

9,10-Bis[N-(m-tolyl)anilino]anthracene>98.0%(HPLC)1g

(2-chloro-5-nitrophenyl)(4-methylphenyl)methanone, 95.0%, 1g